TGA / PMDA / NMPA · Asia-Pacific
maintenance — TGA / PMDA / NMPA regulatory status
maintenance regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 18 published clinical programs and 5 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| 2021/3336 | Phase 3 | George Institute for | 2023-503481-23-00 |
| JPB898 (Induction and Maintenance) | Phase 3 | Sandoz (Japan) | NCT06587451 |
| Ramelteon | Phase 3 | Takeda | NCT00671086, NCT00756002 |
| Tibsovo 250 mg film-coated tablets | Phase 3 | George Institute for | 2024-520219-42-00 |
| CAR-T Cell Therapy + Chidamide and PD-1 Inhibitor Maintenance | Phase 2 | Daihong Liu | NCT07489989 |
| CCRT with Maintenance Tislelizumab and Metronomic Capecitabine | Phase 2 | BEONE MEDICINES AUS | NCT06093061 |
| DRI19220 | Phase 2 | Sanofi-Aventis U.S | 2025-522333-61-00 |
| DURVALUMAB, Ceralasertib | Phase 2 | Istituto Gentili Italia | 2024-515942-18-01 |
| GVA + HDAC Consolidation & Gilteritinib Maintenance | Phase 2 | First People's Hospital | NCT07259707 |
| MR-130A-01 | Phase 2 | Mylan Specialty | 2025-522565-30-00 |
| Ramelteon and doxepin | Phase 2 | Takeda | NCT00755495 |
| Ramelteon and gabapentin | Phase 2 | Takeda | NCT00755508 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 10265372 | Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues | US |
| 8961955 | Maintenance and propagation of mesenchymal stem cells | US |
| 8728724 | Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration | US |
| 8202848 | Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration | US |
| 7784616 | Dispenser for progestin used for acute maintenance treatment of DUB | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of maintenance?
maintenance currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get maintenance regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to maintenance?
This spoke lists 18 published programs associated with maintenance in our pipeline index.